These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26313730)

  • 1. MicroRNAs and mesenchymal stem cells: hope for pulmonary hypertension.
    Zhu Z; Fang Z; Hu X; Zhou S
    Rev Bras Cir Cardiovasc; 2015; 30(3):380-5. PubMed ID: 26313730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension.
    Lee C; Mitsialis SA; Aslam M; Vitali SH; Vergadi E; Konstantinou G; Sdrimas K; Fernandez-Gonzalez A; Kourembanas S
    Circulation; 2012 Nov; 126(22):2601-11. PubMed ID: 23114789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GAPDH is critical for superior efficacy of female bone marrow-derived mesenchymal stem cells on pulmonary hypertension.
    Tan R; Li J; Peng X; Zhu L; Cai L; Wang T; Su Y; Irani K; Hu Q
    Cardiovasc Res; 2013 Oct; 100(1):19-27. PubMed ID: 23801767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal Stem Cells and Lung Transplantation: A Couple for a Perfect Relationship.
    Mohamed MS
    J Stem Cells; 2015; 10(1):63-7. PubMed ID: 26665938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomes: cell garbage can, therapeutic carrier, or trojan horse?
    Thébaud B; Stewart DJ
    Circulation; 2012 Nov; 126(22):2553-5. PubMed ID: 23114790
    [No Abstract]   [Full Text] [Related]  

  • 6. Mesenchymal stem cell therapy in lung disorders: pathogenesis of lung diseases and mechanism of action of mesenchymal stem cell.
    Inamdar AC; Inamdar AA
    Exp Lung Res; 2013 Oct; 39(8):315-27. PubMed ID: 23992090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage Immunomodulation: The Gatekeeper for Mesenchymal Stem Cell Derived-Exosomes in Pulmonary Arterial Hypertension?
    Willis GR; Fernandez-Gonzalez A; Reis M; Mitsialis SA; Kourembanas S
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30150544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspective and challenges of mesenchymal stem cells for cardiovascular regeneration.
    Zhang Y; Liang X; Lian Q; Tse HF
    Expert Rev Cardiovasc Ther; 2013 Apr; 11(4):505-17. PubMed ID: 23570363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension.
    Zhang Y; Liao S; Yang M; Liang X; Poon MW; Wong CY; Wang J; Zhou Z; Cheong SK; Lee CN; Tse HF; Lian Q
    Cell Transplant; 2012; 21(10):2225-39. PubMed ID: 22776744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells restore lung function by recruiting resident and nonresident proteins.
    Jungebluth P; Luedde M; Ferrer E; Luedde T; Vucur M; Peinado VI; Go T; Schreiber C; von Richthofen M; Bader A; Haag J; Darsow KH; Bartel SJ; Lange HA; Furlani D; Steinhoff G; Macchiarini P
    Cell Transplant; 2011; 20(10):1561-74. PubMed ID: 21396162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplantation of mesenchymal stem cells in ALS.
    Mazzini L; Vercelli A; Ferrero I; Boido M; Cantello R; Fagioli F
    Prog Brain Res; 2012; 201():333-59. PubMed ID: 23186722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantation of mesenchymal stem cells improves right ventricular impairments caused by experimental pulmonary hypertension.
    Luan Y; Zhang ZH; Wei DE; Zhao JJ; Kong F; Cheng GH; Wang YB
    Am J Med Sci; 2012 May; 343(5):402-6. PubMed ID: 21876426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regenerative cell and tissue-based therapies for pulmonary arterial hypertension.
    Foster WS; Suen CM; Stewart DJ
    Can J Cardiol; 2014 Nov; 30(11):1350-60. PubMed ID: 25442435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of mesenchymal stem cell-derived microvesicles.
    Biancone L; Bruno S; Deregibus MC; Tetta C; Camussi G
    Nephrol Dial Transplant; 2012 Aug; 27(8):3037-42. PubMed ID: 22851627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paracrine effects and heterogeneity of marrow-derived stem/progenitor cells: relevance for the treatment of respiratory diseases.
    Conese M; Carbone A; Castellani S; Di Gioia S
    Cells Tissues Organs; 2013; 197(6):445-73. PubMed ID: 23652321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomes for drug delivery - a novel application for the mesenchymal stem cell.
    Lai RC; Yeo RW; Tan KH; Lim SK
    Biotechnol Adv; 2013; 31(5):543-51. PubMed ID: 22959595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The therapeutic potential of mesenchymal stem cell-derived extracellular vesicles.
    Katsuda T; Kosaka N; Takeshita F; Ochiya T
    Proteomics; 2013 May; 13(10-11):1637-53. PubMed ID: 23335344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor gene for the treatment of pulmonary hypertension in rats].
    Shang F; He ZX; Wang HW; Cui DB; Yang Y
    Zhonghua Yi Xue Za Zhi; 2011 Jul; 91(26):1847-51. PubMed ID: 22093789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cell-based prostacyclin synthase gene therapy for pulmonary hypertension rats.
    Takemiya K; Kai H; Yasukawa H; Tahara N; Kato S; Imaizumi T
    Basic Res Cardiol; 2010 May; 105(3):409-17. PubMed ID: 19838762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menstrual blood derived mesenchymal cells ameliorate cardiac fibrosis via inhibition of endothelial to mesenchymal transition in myocardial infarction.
    Zhang Z; Wang JA; Xu Y; Jiang Z; Wu R; Wang L; Chen P; Hu X; Yu H
    Int J Cardiol; 2013 Sep; 168(2):1711-4. PubMed ID: 23608402
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.